As Apple Inc. (NASDAQ:AAPL) reports its second-quarter 2024 earnings, CEO Tim Cook has criticized the U.S. Department of Justice’s or DOJ antitrust lawsuit against the tech giant, calling it “misguided.”
What Happened: On Thursday, Apple reported its second-quarter results that outperformed muted goals. During the same time, Cook gave an interview to CNBC and addressed the DOJ’s antitrust lawsuit against the tech giant, reported The Verge.
He called the case “misguided” and promised Apple would contest it. He also expressed concern about the lawsuit becoming a “distraction” for the company.
“I think the case is misguided, and we're going to fight it,” he said, adding, “It's my job to make sure it doesn't become a distraction. And so, you know, if you look at what they're trying to do, is essentially use the law to define how we design products. And that shouldn't be like that.”
Why It Matters: The DOJ filed the lawsuit against Apple in March after a lengthy investigation.
The department alleges that Apple has engaged in anticompetitive behavior by making it difficult for users to switch to other platforms. This included restricting iPhone technologies to its apps and services, keeping iMessage exclusive to Apple devices, limiting third-party digital wallets, and restricting Apple Watch compatibility.
Subscribe to the Benzinga Tech Trends newsletter to get all the latest tech developments delivered to your inbox.
Apple has strongly refuted these claims. The company previously stated that the lawsuit “threatens who we are” and undermines the company’s principles. The company also argues that the lawsuit sets a “dangerous precedent” by allowing governments to dictate how technology is designed.
“We believe this lawsuit is wrong on the facts and the law, and we will vigorously defend against it,” Apple told Benzinga in March in an emailed statement.
Photo Courtesy: Shutterstock.com
Check out more of Benzinga's Consumer Tech coverage by following this link.
Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
